Deep Vein Thrombosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Venous Stasis - Reduced blood flow, often due to prolonged immobility or bed rest, leads to pooling of blood in the deep veins, particularly in the legs. This stagnation increases the risk of clot formation.

• Secondary mechanism: Endothelial Injury - Damage to the inner lining of the blood vessels, which can occur from trauma, surgery, or inflammation, disrupts normal anticoagulant processes and promotes clotting.

• Key complication: Pulmonary Embolism - If the thrombus dislodges, it can travel to the lungs, causing a blockage of a pulmonary artery, which is a life-threatening condition requiring immediate medical attention.

Patient Profile

Demographics:

45-year-old female, office administrator

History:

• Key past medical history: History of hypertension, obesity, and smoking

• Current medications: Lisinopril, Aspirin, Metformin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Swelling and pain in the left leg

• Key symptoms: Redness and warmth in the left leg, mild shortness of breath, fatigue

• Vital signs: Blood pressure 150/95 mmHg, Heart rate 105 bpm, Respiratory rate 22 breaths per minute, Temperature 99.1°F

Section 1

As the nursing team continues to monitor the patient, new diagnostic results reveal significant findings that necessitate immediate attention. A Doppler ultrasound of the left leg confirms the presence of a deep vein thrombosis (DVT) in the popliteal vein. Concurrently, a chest CT scan with contrast is performed due to the patient's mild shortness of breath, which reveals a small embolus in the right lower pulmonary artery, confirming a pulmonary embolism (PE). Laboratory tests show elevated D-dimer levels, consistent with thrombotic activity, and arterial blood gas analysis indicates mild hypoxemia, with a PaO2 of 70 mmHg.

In light of these results, the healthcare team adjusts the treatment plan to address both the DVT and the PE. Anticoagulation therapy is initiated with intravenous heparin to prevent further thrombus formation and reduce the risk of additional emboli. The patient is placed on supplemental oxygen to manage the hypoxemia and improve her respiratory status. The team educates the patient about the potential need for long-term anticoagulation therapy and lifestyle modifications to mitigate risk factors, such as smoking cessation and weight management.

Despite these interventions, the patient experiences a change in status. She begins to report worsening chest pain and increased respiratory distress, with a respiratory rate climbing to 28 breaths per minute and oxygen saturation dropping to 88% on room air. These changes prompt the need for further evaluation and possibly more aggressive interventions, highlighting the complexity of her condition and the need for vigilant monitoring and timely decision-making. The clinical team prepares for potential escalation of care, including the possibility of thrombolytic therapy or surgical intervention, depending on the patient's ongoing response to treatment.

Section 2

The patient's condition continues to evolve as the nursing team conducts an initial reassessment in response to her worsening symptoms. Vital signs are promptly reevaluated, revealing a blood pressure of 102/65 mmHg, heart rate of 115 beats per minute, and a respiratory rate of 30 breaths per minute. Oxygen saturation remains low at 88% on room air, and the patient appears anxious and diaphoretic, with audible wheezing upon auscultation. The clinical team also notes the presence of jugular venous distension, suggesting increased right heart strain possibly due to the pulmonary embolism.

Given these findings, the team suspects the development of acute right heart failure secondary to worsening pulmonary embolism. A repeat arterial blood gas analysis shows further decline in respiratory status, with a PaO2 of 65 mmHg and a PaCO2 of 50 mmHg, indicating respiratory acidosis. The escalating respiratory distress and hemodynamic instability prompt the urgent need for a more aggressive intervention. The healthcare team consults with the pulmonologist and cardiologist to consider the initiation of thrombolytic therapy, given the patient's current risk of significant cardiopulmonary compromise.

As the team deliberates on the next steps, they remain vigilant for other potential complications such as bleeding risks associated with thrombolytic therapy, given the patient's anticoagulation treatment with heparin. The decision-making process involves weighing the benefits of resolving the embolus against the risks, emphasizing the importance of timely intervention to prevent further deterioration. The patient's family is informed of the situation, providing consent for thrombolytic therapy while being educated on the potential outcomes and necessary monitoring. This phase of care underscores the complexity of managing a patient with concurrent DVT and PE, demanding continual reassessment and critical thinking from the healthcare team.

Section 3

As the healthcare team proceeds with thrombolytic therapy, the patient is transferred to the intensive care unit for closer monitoring and management. Within a few hours of initiating the treatment, the team observes a slight improvement in the patient's respiratory status. Her oxygen saturation rises to 92% with supplemental oxygen via a non-rebreather mask, and her respiratory rate decreases to 24 breaths per minute. The heart rate remains elevated at 110 beats per minute, but her blood pressure stabilizes at 110/70 mmHg. These changes suggest a modest positive response to the thrombolytic therapy, alleviating some of the acute strain on her right heart.

However, the patient soon develops new complications, which demand immediate attention. She begins to complain of sudden onset severe abdominal pain and exhibits signs of tenderness upon palpation. The nursing team notes a drop in her hemoglobin levels from 13 g/dL to 10 g/dL, raising concerns for potential internal bleeding, a known risk associated with thrombolytic therapy. An urgent abdominal ultrasound is ordered, revealing the presence of free fluid in the peritoneal cavity, indicative of a possible intra-abdominal hemorrhage.

These findings necessitate a prompt multidisciplinary discussion to balance the continuation of thrombolytic therapy against the risk of further bleeding. The team evaluates the need for potential surgical intervention while considering the use of reversal agents for the thrombolytic therapy. The patient's care plan is adjusted to include increased frequency of vital sign monitoring and laboratory tests to track her hemoglobin levels and coagulation status meticulously. The situation underscores the critical need for continuous assessment and agile decision-making to optimize the patient's outcomes amidst evolving challenges.

Section 4

As the team deliberates on the next steps, the patient's condition begins to show signs of further deterioration. Her abdominal pain intensifies, and her heart rate climbs to 125 beats per minute, indicating a possible compensatory response to the developing hypovolemia. Despite the heart rate increase, her blood pressure starts to drop, now reading 95/60 mmHg, suggesting a progression towards hemodynamic instability. The patient's skin becomes cool and clammy, and her mental status starts to fluctuate, with periods of confusion interspersed with lucid intervals. These clinical findings raise alarms about the potential severity of the internal bleeding and the need for immediate intervention.

A repeat hemoglobin test reveals a further decline to 8.5 g/dL, confirming ongoing blood loss. The team quickly initiates a transfusion of packed red blood cells to stabilize her hemoglobin levels, while simultaneously consulting with the surgical team to evaluate the necessity of an exploratory laparotomy. The potential for surgical intervention is considered alongside the risks associated with the patient's fragile condition and ongoing thrombolytic therapy.

Meanwhile, the patient is placed on continuous telemetry to closely monitor her cardiac function, given the stress on her cardiovascular system. The nursing team increases the frequency of her vital signs assessments to every 15 minutes and intensifies the monitoring of her fluid balance. Despite the challenges, the team remains vigilant and proactive, adjusting her care plan in real-time to address the complexities of her condition. The focus remains on carefully balancing the benefits of ongoing thrombolytic therapy with the imperative to control the source of the bleeding, ensuring that all potential complications are managed with precision and foresight.

Section 5

The team continues to be on high alert as they monitor the patient's response to the blood transfusion and ongoing thrombolytic therapy. After the transfusion of two units of packed red blood cells, the patient's hemoglobin level shows a modest improvement, rising to 9.2 g/dL. However, despite this intervention, her blood pressure remains low at 92/58 mmHg, and her heart rate persists at 120 beats per minute. Her skin remains cool and clammy, and her mental status fluctuates, with increasing periods of confusion. There is a growing concern that the blood loss might be more significant than initially estimated or that there might be a delay in the physiological response to the transfusion.

The consulting surgical team decides to proceed with an urgent exploratory laparotomy due to the risk of significant intra-abdominal bleeding. Pre-operative preparations are expedited with the patient receiving intravenous fluids to support her hemodynamic status. Meanwhile, a repeat coagulation profile is conducted to assess the impact of thrombolytic therapy on her clotting status. The results reveal a slightly prolonged activated partial thromboplastin time (aPTT) and international normalized ratio (INR), indicative of the delicate balance between preventing further thrombus formation and exacerbating bleeding risks.

As the patient is prepped for surgery, the nursing team remains focused on maintaining stability, ensuring that she is adequately hydrated and monitoring for any signs of further deterioration. The interdisciplinary team collaborates closely, weighing the risks of surgery against the potential benefits of addressing the suspected bleeding source. This scenario highlights the complexity of managing a patient with dual concerns of thrombosis and hemorrhage, challenging the team to apply their clinical reasoning to anticipate and mitigate potential complications. The path forward involves a well-coordinated effort to stabilize the patient intra-operatively and post-operatively, with plans for ongoing monitoring and adjustment of her therapeutic regimen based on her evolving clinical picture.